Literature DB >> 22144500

A population-based study of prevalence and adherence trends in average risk colorectal cancer screening, 1997 to 2008.

Pamela S Sinicrope1, Ellen L Goode, Paul J Limburg, Sally W Vernon, Joseph B Wick, Christi A Patten, Paul A Decker, Andrew C Hanson, Christina M Smith, Timothy J Beebe, Frank A Sinicrope, Noralane M Lindor, Tabetha A Brockman, L Joseph Melton, Gloria M Petersen.   

Abstract

BACKGROUND: Increasing colorectal cancer screening (CRCS) is important for attaining the Healthy People 2020 goal of reducing CRC-related morbidity and mortality. Evaluating CRCS trends can help identify shifts in CRCS, and specific groups that might be targeted for CRCS.
METHODS: We utilized medical records to describe population-based adherence to average-risk CRCS guidelines from 1997 to 2008 in Olmsted County, MN. CRCS trends were analyzed overall and by gender, age, and adherence to screening mammography (women only). We also carried out an analysis to examine whether CRCS is being initiated at the recommended age of 50.
RESULTS: From 1997 to 2008, the size of the total eligible sample ranged from 20,585 to 21,468 people. CRCS increased from 22% to 65% for women and from 17% to 59% for men (P < 0.001 for both) between 1997 and 2008. CRCS among women current with mammography screening increased from 26% to 74%, and this group was more likely to be adherent to CRCS than all other subgroups analyzed (P < 0.001).The mean ages of screening initiation were stable throughout the study period, with a mean age of 55 years among both men and women in 2008.
CONCLUSION: Although overall CRCS tripled during the study period, there is still room for improvement. IMPACT: Working to decrease the age at first screening, exploration of gender differences in screening behavior, and targeting women adherent to mammography but not to CRCS seem warranted. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 22144500      PMCID: PMC3339802          DOI: 10.1158/1055-9965.EPI-11-0818

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

Review 1.  Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States.

Authors:  R M Pinkhasov; J Wong; J Kashanian; M Lee; D B Samadi; M M Pinkhasov; R Shabsigh
Journal:  Int J Clin Pract       Date:  2010-03       Impact factor: 2.503

Review 2.  Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases.

Authors:  Hilal Maradit Kremers; Cynthia S Crowson; Sherine E Gabriel
Journal:  Rheum Dis Clin North Am       Date:  2004-11       Impact factor: 2.670

3.  Trends in colonoscopy for colorectal cancer screening.

Authors:  Kathryn A Phillips; Su-Ying Liang; Uri Ladabaum; Jennifer Haas; Karla Kerlikowske; David Lieberman; Robert Hiatt; Mika Nagamine; Stephanie L Van Bebber
Journal:  Med Care       Date:  2007-02       Impact factor: 2.983

4.  Associations in breast and colon cancer screening behavior in women.

Authors:  Ruth C Carlos; A Mark Fendrick; Stephanie K Patterson; Steven J Bernstein
Journal:  Acad Radiol       Date:  2005-04       Impact factor: 3.173

5.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

6.  Validity of self-reported colorectal cancer screening behavior.

Authors:  M Baier; N Calonge; G Cutter; M McClatchey; S Schoentgen; S Hines; A Marcus; D Ahnen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-02       Impact factor: 4.254

7.  Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter?

Authors:  Sally W Vernon; Jasmin A Tiro; Rachel W Vojvodic; Sharon Coan; Pamela M Diamond; Anthony Greisinger; Maria E Fernandez
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

8.  Underuse of screening sigmoidoscopy and colonoscopy in a large cohort of US adults.

Authors:  Ann Chao; Cari J Connell; Vilma Cokkinides; Eric J Jacobs; Eugenia E Calle; Michael J Thun
Journal:  Am J Public Health       Date:  2004-10       Impact factor: 9.308

9.  Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?

Authors:  Ruth C Carlos; A Mark Fendrick; James Ellis; Steven J Bernstein
Journal:  J Am Coll Radiol       Date:  2004-10       Impact factor: 5.532

10.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Robert A Smith; Durado Brooks; Kimberly S Andrews; Chiranjeev Dash; Francis M Giardiello; Seth Glick; Theodore R Levin; Perry Pickhardt; Douglas K Rex; Alan Thorson; Sidney J Winawer
Journal:  CA Cancer J Clin       Date:  2008-03-05       Impact factor: 508.702

View more
  10 in total

1.  Patterns of colorectal cancer screening uptake in newly eligible men and women.

Authors:  Karen J Wernli; Rebecca A Hubbard; Eric Johnson; Jessica Chubak; Aruna Kamineni; Beverly B Green; Carolyn M Rutter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-05-03       Impact factor: 4.254

2.  Examining connections between screening for breast, cervical and prostate cancer and colorectal cancer screening.

Authors:  Michael D Wirth; Heather M Brandt; Heather Dolinger; James W Hardin; Patricia A Sharpe; Jan M Eberth
Journal:  Colorectal Cancer       Date:  2014-06

3.  Colorectal Cancer Incidence Patterns in the United States, 1974-2013.

Authors:  Rebecca L Siegel; Stacey A Fedewa; William F Anderson; Kimberly D Miller; Jiemin Ma; Philip S Rosenberg; Ahmedin Jemal
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

4.  Understanding Patient and Clinical Stakeholder Perspectives to Improve Adherence to Lung Cancer Screening.

Authors:  Karen J Wernli; Leah Tuzzio; Sarah Brush; Kelly Ehrlich; Hongyuan Gao; Melissa L Anderson; Lorella Palazzo
Journal:  Perm J       Date:  2021-06-02

5.  Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.

Authors:  Janet S de Moor; Robin A Cohen; Jean A Shapiro; Marion R Nadel; Susan A Sabatino; K Robin Yabroff; Stacey Fedewa; Richard Lee; V Paul Doria-Rose; Cheryl Altice; Carrie N Klabunde
Journal:  Prev Med       Date:  2018-05-03       Impact factor: 4.018

6.  Determinants of variations in self-reported barriers to colonoscopy among uninsured patients in a primary care setting.

Authors:  Chinedum Ojinnaka; Ann Vuong; Janet Helduser; Philip Nash; Marcia G Ory; David A McClellan; Jane N Bolin
Journal:  J Community Health       Date:  2015-04

7.  Defining and measuring adherence to cancer screening.

Authors:  Jessica Chubak; Rebecca Hubbard
Journal:  J Med Screen       Date:  2016-03-04       Impact factor: 2.136

8.  Ethnic differences and predictors of colonoscopy, prostate-specific antigen, and mammography screening participation in the multiethnic cohort.

Authors:  Brook E Harmon; Melissa A Little; Erica D Woekel; Reynolette Ettienne; Camonia R Long; Lynne R Wilkens; Loic Le Marchand; Brian E Henderson; Laurence N Kolonel; Gertraud Maskarinec
Journal:  Cancer Epidemiol       Date:  2014-03-22       Impact factor: 2.984

9.  A Microbiomic Analysis in African Americans with Colonic Lesions Reveals Streptococcus sp.VT162 as a Marker of Neoplastic Transformation.

Authors:  Hassan Brim; Shibu Yooseph; Edward Lee; Zaki A Sherif; Muneer Abbas; Adeyinka O Laiyemo; Sudhir Varma; Manolito Torralba; Scot E Dowd; Karen E Nelson; Wimal Pathmasiri; Susan Sumner; Willem de Vos; Qiaoyi Liang; Jun Yu; Erwin Zoetendal; Hassan Ashktorab
Journal:  Genes (Basel)       Date:  2017-11-09       Impact factor: 4.096

10.  Microbiome analysis of stool samples from African Americans with colon polyps.

Authors:  Hassan Brim; Shibu Yooseph; Erwin G Zoetendal; Edward Lee; Manolito Torralbo; Adeyinka O Laiyemo; Babak Shokrani; Karen Nelson; Hassan Ashktorab
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.